measles, mumps, rubella, varicella vaccine (ProQuad) Report issue

Vaccine Approved FDA
AACT MeSH

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

  • Mechanisms of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

measles, mumps, rubella and chickenpox | measles, mumps, rubella and varicella | measles-mumps-rubella-varicella vaccine | measles, mumps, rubella, varicella vaccine | mmrv vaccine | proquad | pro-quad | virus, live attenuated, measles, virus, live attenuated, mumps, virus, live attenuated, rubella, virus, live attenuated, varicella

Organizations (7)

Research & Development (7)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (19)

Approved Indications (2)


 

Varicella Zoster Virus Infection (approved 2005)

Virus Diseases (approved 2005)

Experimental Indications - Clinical Trial Phases 1-4 (18)


 

Bacterial Infections (Phase 3)

Chickenpox (Phase 4)

Diphtheria (Phase 3)

Haemophilus Infections (Phase 3)

Heart Diseases (Phase 1/Phase 2)

Hepatitis A (Phase 4)

Hepatitis A virus (Phase 4)

Hepatitis B (Phase 3)

Liver Failure, Acute (Phase 1/Phase 2)

Measles (Phase 4)

Meningitis, Meningococcal (Phase 3)

Mumps (Phase 4)

Poliomyelitis (Phase 3)

Renal Insufficiency, Chronic (Phase 1/Phase 2)

Rubella (Phase 4)

Tetanus (Phase 3)

Virus Diseases (Phase 3)

Whooping Cough (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 18
  • # of Trial Organizations: 7

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue